Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb Study of ASP1941 Plus Metformin in Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
2009-013881-25Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ipragliflozin in type 2 diabetes mellitus (T2DM) (5 arms), sponsored by Astellas Pharma. Primary endpoint: Change from baseline in HbA1c at Week 12. Started Jan 2010; status: completed.
02
Drugs
ipragliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-013881-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013881-25.